BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Diagnosis
26 results:

  • 1. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
    Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; MCourt CK; Mutch DG; Powell MA; Siegel CL
    Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report.
    Teti C; Bezante G; Gatto F; Khorrami Chokami K; Albertelli M; Falchi M; Bovio G; Nati ST; Ferone D; Boschetti M
    BMC Endocr Disord; 2023 May; 23(1):123. PubMed ID: 37246209
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pituitary and adrenal disorders induced by immune checkpoint inhibitors.
    Albarel F; Brue T; Castinetti F
    Ann Endocrinol (Paris); 2023 May; 84(3):339-345. PubMed ID: 36965852
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Radiation of bilateral adrenal metastases is associated with a high risk of primary adrenal insufficiency.
    Herndon J; Hallemeier C; Jethwa K; Shariff A; Bancos I
    Clin Endocrinol (Oxf); 2023 Jul; 99(1):35-42. PubMed ID: 36905107
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Photoacoustic Contrast Nanoagent with a Distinct Spectral Signature for Ovarian cancer Management.
    St Lorenz A; Moses AS; Mamnoon B; Demessie AA; Park Y; Singh P; Taratula O; Taratula OR
    Adv Healthc Mater; 2023 Apr; 12(9):e2202946. PubMed ID: 36495088
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Side-chain cleavage enzyme deficiency: Systematic review and case series.
    Phadte A; Arya S; Sarathi V; Lila A; Maheshwari M; Memon SS; Rane A; Patil V; Rai K; Raghav D; Kunwar A; Bandgar T
    Clin Endocrinol (Oxf); 2023 Mar; 98(3):351-362. PubMed ID: 36357326
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.
    Zhu Y; Zheng D; Lei L; Cai K; Xie H; Zheng J; Yu C
    BMC Cancer; 2022 Oct; 22(1):1042. PubMed ID: 36199068
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cortisol Deficiency in Lenvatinib Treatment of Thyroid cancer: An Underestimated Common Adverse Event.
    Monti S; Presciuttini F; Deiana MG; Motta C; Mori F; Renzelli V; Stigliano A; Toscano V; Pugliese G; Poggi M
    Thyroid; 2022 Jan; 32(1):46-53. PubMed ID: 34663079
    [No Abstract]    [Full Text] [Related]  

  • 9. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic cancer.
    Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Bilateral testicular masses and adrenal insufficiency: is congenital adrenal hyperplasia the only possible diagnosis? First two cases of TARTS described in Addison-only X-linked adrenoleukodystrophy and a brief review of literature.
    Tresoldi AS; Betella N; Hasenmajer V; Pozza C; Vena W; Fiamengo B; Negri L; Cappa M; Lania AGA; Lenzi A; Isidori AM; Pizzocaro A
    J Endocrinol Invest; 2021 Mar; 44(3):391-402. PubMed ID: 32691371
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Presentation, disease progression and outcomes of adrenal gland metastases.
    Mao JJ; Dages KN; Suresh M; Bancos I
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):546-554. PubMed ID: 32569405
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Posterior Adiposity Index: A Quantitative Selection Tool for Adrenalectomy Approach.
    Lindeman B; Gawande AA; Moore FD; Cho NL; Doherty GM; Nehs MA
    J Surg Res; 2019 Jan; 233():26-31. PubMed ID: 30502257
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy.
    Colombo C; De Leo S; Di Stefano M; Vannucchi G; Persani L; Fugazzola L
    J Clin Endocrinol Metab; 2019 Mar; 104(3):779-784. PubMed ID: 30383218
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Primary adrenal insufficiency due to bilateral infiltrative disease.
    Herndon J; Nadeau AM; Davidge-Pitts CJ; Young WF; Bancos I
    Endocrine; 2018 Dec; 62(3):721-728. PubMed ID: 30178435
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
    Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
    J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and pai-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian cancer: A Study of the Tumor Bank Ovarian cancer Network.
    Koensgen D; Stope MB; Tuerbachova I; Bruennert D; Kohlmann T; Braicu I; Sehouli J; Denkert C; Darb-Esfahani S; Stickeler E; Sofroni D; Dahl E; Mustea A
    Gynecol Obstet Invest; 2018; 83(5):508-514. PubMed ID: 28738361
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [An IgG4-related pancreatitis mimicking an adenocarcinoma: A case report].
    Courcet E; Beltjens F; Charon-Barra C; Guy F; Orry D; Ghiringhelli F; Arnould L
    Ann Pathol; 2015 Dec; 35(6):511-4. PubMed ID: 26596693
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer.
    Huang YJ; Frazier ML; Zhang N; Liu Q; Wei C
    Dig Dis Sci; 2014 May; 59(5):968-75. PubMed ID: 24248418
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance.
    Zhang W; Ling D; Tan J; Zhang J; Li L
    Oncol Rep; 2013 Feb; 29(2):637-45. PubMed ID: 23174953
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
    Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
    J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.